A detailed history of Kelly Financial Services LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kelly Financial Services LLC holds 1,393 shares of ABBV stock, worth $239,219. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,393
Previous 1,317 5.77%
Holding current value
$239,219
Previous $225,000 22.22%
% of portfolio
0.11%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $12,451 - $15,149
76 Added 5.77%
1,393 $275,000
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $69,036 - $80,618
446 Added 51.21%
1,317 $225,000
Q1 2024

Jul 17, 2024

BUY
$159.82 - $182.1 $11,027 - $12,564
69 Added 8.6%
871 $158,000
Q4 2023

Jul 17, 2024

BUY
$137.6 - $154.97 $20,089 - $22,625
146 Added 22.26%
802 $124 Million
Q3 2023

Jul 17, 2024

SELL
$133.59 - $154.65 $4,942 - $5,722
-37 Reduced 5.34%
656 $97.8 Million
Q2 2023

Jul 17, 2024

BUY
$132.51 - $164.9 $28,887 - $35,948
218 Added 45.89%
693 $93.3 Million
Q1 2023

Jul 17, 2024

BUY
$144.61 - $166.54 $13,159 - $15,155
91 Added 23.7%
475 $75.7 Million
Q4 2022

Jul 17, 2024

BUY
$138.31 - $165.87 $414 - $497
3 Added 0.79%
384 $62 Million
Q3 2022

Jul 17, 2024

BUY
$134.21 - $153.93 $268 - $307
2 Added 0.53%
381 $51.2 Million
Q2 2022

Jul 17, 2024

BUY
$137.62 - $174.96 $412 - $524
3 Added 0.8%
379 $58 Million
Q1 2022

Jul 17, 2024

BUY
$131.98 - $163.75 $263 - $327
2 Added 0.53%
376 $61 Million
Q4 2021

Jul 17, 2024

BUY
$107.43 - $135.93 $322 - $407
3 Added 0.81%
374 $50.6 Million
Q3 2021

Jul 17, 2024

SELL
$106.4 - $120.78 $4.38 Million - $4.97 Million
-41,143 Reduced 99.11%
371 $40 Million
Q2 2021

Jul 17, 2024

BUY
$105.21 - $117.21 $4.33 Million - $4.82 Million
41,148 Added 11242.62%
41,514 $369,000
Q1 2021

Jul 17, 2024

BUY
$102.3 - $112.62 $1,329 - $1,464
13 Added 3.68%
366 $39.6 Million
Q4 2020

Jul 17, 2024

BUY
$80.49 - $108.67 $241 - $326
3 Added 0.86%
353 $37.9 Million
Q3 2020

Jul 17, 2024

SELL
$85.91 - $100.83 $8,591 - $10,083
-100 Reduced 22.22%
350 $30.7 Million
Q2 2020

Jul 17, 2024

BUY
$73.37 - $98.18 $1,760 - $2,356
24 Added 5.63%
450 $44.1 Million
Q1 2020

Jul 17, 2024

BUY
$64.5 - $97.79 $5,869 - $8,898
91 Added 27.16%
426 $32.4 Million
Q3 2019

Jul 17, 2024

SELL
$62.98 - $75.72 $4,723 - $5,679
-75 Reduced 18.29%
335 $25.4 Million
Q2 2019

Jul 17, 2024

BUY
$65.7 - $83.98 $657 - $839
10 Added 2.5%
410 $29.8 Million
Q1 2019

Jul 17, 2024

BUY
$77.14 - $90.79 $30,856 - $36,316
400 New
400 $32.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.